Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ryuma Tanaka MD

Ryuma Tanaka MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center
Member of the Center for Immunology
Member of the Neuroscience Research Center


Publications (11)

  • Dual inhibition of BRAF and mTOR in BRAF V600E -mutant pediatric, adolescent, and young adult brain tumors. (Sen S, Tanaka R, Khatua S, Zaky W, Janku F, Penas-Prado M, Weathers SP, Behrang A, Roszik J, Subbiah V) Cold Spring Harb Mol Case Stud 2020 Aug;6(4) PMID: 32843426 08/28/2020    
  • Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era. (Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS) Curr Oncol Rep 2019 11 25;21(12):104 PMID: 31768799 SCOPUS ID: 2-s2.0-85075563534 11/27/2019       1 Citation
  • Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function. (Caruso HG, Tanaka R, Liang J, Ling X, Sabbagh A, Henry VK, Collier TL, Heimberger AB) J Neurooncol 2019 Dec;145(3):429-439 PMID: 31686330 11/07/2019       1 Citation
  • Immunotherapeutic options for pediatric malignancies. (Tanaka R, Heimberger AB) Current Immunology Reviews 2016;12(2):63-73 08/06/2019    
  • EPT-17 Phase I Study of BRAF Inhibitor (Vemurafenib) in combination with the mTOR inhibitor (Everolimus) in BRAFV600E positive childhood and AYA brain tumors (Tanaka R, Khatua S, Zaky W, Penas-Prado M, Weathers S-P, Subbiah V.) Neuro-Oncology 2016;18(suppl 3):iii27. 08/06/2019    
  • IMMU-17. Reducing the ex vivo manufacturing time of EGFRVIII-specific chimeric antigen receptor (CAR) T cells improves phenotype and demonstrates potent anti-glioma function in vivo. (Tanaka R, Caruso H, Ling X, Heimberger AB.) Neuro-Oncology 2017;19(suppl 6):vi116 08/06/2019    
  • Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. (Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C, BouĂ© DR, Rauch TM, Boyd JT, Chen J, Corbo JC, Bouldin TW, Elton SW, Liu LL, Schofield D, Lee SC, Bouffard JP, Georgescu MM, Dossani RH, Aguiar MA, Sances RA, Saad AG, Boop FA, Qaddoumi I, Ellison DW) Neuro Oncol 2019 06 10;21(6):800-808 PMID: 30726976 PMCID: PMC6556860 02/07/2019       8 Citations
  • Predicting outcomes of neonates born to GBS-positive women who received inadequate intrapartum antimicrobial prophylaxis. (Kojima K, Tanaka R, Nakajima K, Kurihara N, Oba MS, Yamashita Y, Ishihara J, Yahagi N) Turk J Pediatr 2014 May-Jun;56(3):238-42 PMID: 25341594 10/25/2014       2 Citations
  • Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report. (Tanaka R, Osumi T, Miharu M, Ishii T, Hasegawa T, Takahashi T, Shimada H) Exp Hematol Oncol 2012 Apr 19;1(1):8 PMID: 23211036 PMCID: PMC3514085 12/06/2012    
  • Congenital corneal staphyloma as a complication of Kabuki syndrome. (Tanaka R, Takenouchi T, Uchida K, Sato T, Fukushima H, Yoshihashi H, Takahashi T, Tsubota K, Kosaki K) Am J Med Genet A 2012 Aug;158A(8):2000-2 PMID: 22786791 07/13/2012       7 Citations
  • Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD. (Osumi T, Miharu M, Tanaka R, Du W, Takahashi T, Shimada H) Bone Marrow Transplant 2012 Jan;47(1):139-40 PMID: 21339748 02/23/2011       6 Citations
  • Last update: 09/11/2020
    jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280